High cost oncology drugs without proof of added benefit are burdening health systems
- PMID: 38423553
- DOI: 10.1136/bmj.q511
High cost oncology drugs without proof of added benefit are burdening health systems
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at https://icmje.org/disclosure-of-interest/ and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources